What is the clinical evidence from this study?

Study design: Review. Intervention: Angiotensin II AT1 Receptor Antagonists.

May 8, 2003Journal of Medicinal ChemistryOpen Access

Angiotensin II AT1 Receptor Antagonists. Clinical Implications of Active Metabolites

View Full Paper

Ask AI

Bookmark

Key result

This review discusses the clinical implications of active metabolites of Angiotensin II AT1 receptor antagonists.

Authors

BSBoris SchmidtAgaplesion Bethanien Krankenhaus BSBernhard SchiefferInterventional Cardiology

Discussion

Member takes

Implication

Active metabolites may refine ARB selection; leaves open their outcome impact pending prospective data.

PICO

Exposure / Comparator

Angiotensin II AT1 Receptor Antagonists

Cite This Study

Schmidt et al. (2003) reported a review. Angiotensin II AT1 Receptor Antagonists was evaluated. This review discusses the clinical implications of active metabolites of Angiotensin II AT1 receptor antagonists.

synapsesocial.com/papers/6a7865572e130d02afed2059 https://doi.org/10.1021/jm0204237

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Angiotensin II AT1 Receptor Antagonists. Clinical Implications of Active Metabolites

Discussion

Member takes

Implication

PICO

Cite This Study

Topics

Angiotensin II AT1 Receptor Antagonists. Clinical Implications of Active Metabolites

Discussion

Member takes

Implication

PICO

Cite This Study

Also Consider

Topics

Also Consider